about
Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever populationPulmonary alveolar proteinosis in a cat.Red blood cell phosphate concentration and osmotic resistance during dietary phosphate depletion in dairy cowsMulti-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma.Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.Cytology of endoscopically obtained biopsies for the diagnosis of chronic intestinal diseases in cats.A longitudinal study of ABC transporter expression in canine multicentric lymphoma.Effects of an iodine-restricted food on client-owned cats with hyperthyroidism.Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.Causes of death and the impact of histiocytic sarcoma on the life expectancy of the Dutch population of Bernese mountain dogs and Flat-coated retrievers.Serial serum feline pancreatic lipase immunoreactivity concentrations and prognostic variables in 33 cats with pancreatitis.Use of bandage contact lenses for treatment of spontaneous chronic corneal epithelial defects in dogs.Development of tear production and intraocular pressure in healthy canine neonates.Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers.Compartmental resection of peripheral nerve tumours with limb preservation in 16 dogs (1995-2011).Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network studyEfficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shuntsPrednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy resultsBioavailability of cyclophosphamide and vincristine after intraperitoneal administration in catsCorrelation of clinical, diagnostic and histopathological parameters in dogs with chronic lymphocytic-plasmacytic enteropathyRespiratory rate of clinically healthy cats measured in veterinary consultation roomsCorrelation between the FCEAI and diagnostic parameters in chronic enteropathies in 147 cats (2006-2012)Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours[Evaluation of sonographic parameters as prognostic risk factors in cats with pancreatitis - A retrospective study in 42 cats]Molecular markers of prognosis in canine cortisol-secreting adrenocortical tumoursThe Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours
P50
Q28659531-B2D8B77A-FD69-485C-8531-7A123AB400ADQ35863387-60709E98-B6B7-4BA2-8C83-A0D60F4BEE98Q36873607-01BEEF81-ACE3-4FA7-A614-F8E01D5DC908Q38979920-124B119B-3196-4B34-84D5-D9DE685D8F6EQ39326831-FD35FAC4-B96B-4A34-9121-77B0FA77AB89Q41564183-C9420E56-6F98-4C7E-829B-ACFE3B3F1F2AQ41727264-1D269F86-90B5-49D1-A563-002C39401A06Q42628079-5DB8BEC3-2BA0-46C5-A3EE-5A904F42302FQ43185759-A21E4E72-7CBD-427E-8B81-6D670F8C019AQ44545081-D7C7E7D2-B49E-497F-A9F4-E807C403D7B3Q44633902-D7056E00-EBE8-41D6-9B7A-D41170830A5BQ47720020-43B6ADA0-2259-4E1C-8A9D-E85CFD39344BQ47840478-01E43610-2419-4FFB-B5AC-C461766ED86BQ49594154-25E797C9-213E-4329-90B1-BFF1A1F9C0CBQ50084753-6ACD765D-EB97-4E63-8953-42144D9EE867Q51747597-24C55909-8CC9-40BF-854A-B57501EE2EC6Q58798888-425E2600-2A34-418D-88D2-64EB41C60D99Q64113498-038838DC-BF01-439A-A8DE-16C058EAECDBQ86917240-1BDDD313-F2C4-4982-AB95-3D443533123FQ87632086-F16A1F47-AEDC-493C-922C-BF604E7E1DE9Q88047827-89081DCD-DCC0-4B3A-A74D-5AAB84E844BCQ88430506-9BC18683-47E8-4460-A9FF-0FC9DE00B087Q89821306-E0E70BF4-A2B3-452D-8B59-400D26661568Q90769687-A31DE126-6817-431D-8194-63E7B87BB1D7Q91113328-2468B936-6D83-4DBF-A9CB-34663657CE10Q91845554-1BF7DB48-4B9E-4DF5-B85C-8E71B365A284Q92297589-BD104105-B772-41AF-8B2D-C56FC3111AB5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Erik Teske
@en
Erik Teske
@nl
type
label
Erik Teske
@en
Erik Teske
@nl
prefLabel
Erik Teske
@en
Erik Teske
@nl
P31
P496
0000-0002-7521-8173